FTC Extends Antitrust Review Of Barr Acquisition
The U.S. Federal Trade Commission has made a second request for information in its antitrust review of Barr Laboratories acquisition of European generic drug giant, Pliva....To view the full article, register now.
Already a subscriber? Click here to view full article